Aflofarm Pharmacy Poland has obtained the decision of the President of the Office for Registration of Medicinal Products to change the availability category of Inventum, containing sildenafil 25 mg, over-the-counter. The drug has an innovative form of chewing and chewing tablets.

Aflofarm Pharmacy Poland has obtained the decision of the President of the Office for Registration of Medicinal Products to change the availability category of Inventum, containing sildenafil 25 mg, over-the-counter. The drug has an innovative form of chewing and chewing tablets. Each Inventum package will include a self-diagnostic test that will allow the patient to make a safe decision about how to use the product independently. The test content was confirmed by a large number of patients. The study was considered important by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. In order to ensure the safe use of Inventum, Aflofarm will also carry out a series of actions for patients and pharmacists: - Patient education will be conducted through the information included in the test, included in the product packaging. In addition, we will conduct actions directed to pharmacists to update knowledge about cardiovascular risk assessment in patients with erectile dysfunction and contraindications and warnings to be considered before the release of the product, and to indicate the need to inform patients of the need to read the leaflet and complete the test before admission. , says Hanna Wahl, Development Director at Aflofarm Pharmacy Poland. Inventum contains 25 mg of sildenafil, a substance that has only recently been prescribed by a physician. This is an organic compound that was first introduced to the market in 1998 as a recognizable blue tablet for the treatment of erectile dysfunction. Inventum will be available in pharmacies in December. This is another drug introduced by Aflofarm Pharmacy Poland recently. In November, the company introduced Dafurag Max, which contains the highest dose of furezidine in Europe.